Catterton Partners acquires StriVectin

Published: 14-Jul-2009

Private equity firm Catterton Partners has announced it has purchased the premium skin care brand StriVectin from Klein-Becker.


Private equity firm Catterton Partners has announced it has purchased the premium skin care brand StriVectin from Klein-Becker.

The acquisition was completed by Catterton’s holding company Chrysallis, which will now lead the new company under the guidance of ceo Melisse Shaban and cmo Jill Scalamandre.

The StriVectin brand will join Chrysallis’ extensive portfolio, which includes a number of food, beverage, retail, restaurant and consumer goods brand. Last year it sold the Frédéric Fekkai brand to P&G.

“The StriVectin brand is well positioned for today’s consumer wanting efficacious, solution-focused skin treatments with proven results,” said Scalamandre. “Going forward we see opportunities to address a wider range of skin care needs for a more diverse base of consumers in a broader range of markets.”

You may also like